Top

Published in:

Open Access 01-12-2014 | Review

Pulmonary metastasis of giant cell tumor of bones

Authors: Aikeremujiang Muheremu, Xiaohui Niu

Published in: World Journal of Surgical Oncology | Issue 1/2014

Abstract

Giant cell tumor of bone (GCTB) accounts for 5% of primary skeletal tumors. Although it is considered to be a benign lesion, there are still incidences of pulmonary metastasis. Pulmonary metastasis of GCTB may be affected by tumor grading and localization as well as the age, gender and overall health status of the patient. Patients with local recurrence are more likely to develop pulmonary metastasis of GCTB. High expression of some genes, cytokines and chemokines may also be closely related to the metastatic potential and prognosis of GCTB. The treatment of the primary GCTB is key to the final outcome of the disease, as intralesional curettage has a significantly higher local recurrence and pulmonary metastasis rate than wide resection. However, even patients with pulmonary metastasis seem to have a good prognosis after timely and appropriate surgical resection. It is hoped that with the development of novel surgical methods and drugs, pulmonary metastasis of GCTB can be prevented and treated more effectively.

Available only for authorised users

Campanacci M, Baldini N, Boriani S, Sudanese A: Giant-cell tumor of bone. J Bone Joint Surg Am. 1987, 69: 106-114.PubMed

Enneking WF: Musculoskeletal Tumor Surgery. 1983, New York (NY): Churchil Livingstone, Inc.

Feigenberg SJ, Marcus RB, Zlotecki RA, Scarborough MT, Enneking WF: Whole-lung radiotherapy for giant cell tumors of bone with pulmonary metastases. Clin Orthop Relat Res. 2002, 401: 202-208.CrossRefPubMed

Anazawa U, Hanaoka H, Shiraishi T, Morioka H, Morii T, Toyama Y: Similarities between giant cell tumor of bone, giant cell tumor of tendon sheath, and pigmented villonodular synovitis concerning ultrastructural cytochemical features of multinucleated giant cells and mononuclear stromal cells. Ultrastruct Pathol. 2006, 30: 151-158.CrossRefPubMed

Lindeman JH, Hanemaai jer R, Mulder A, Dijkstra PD, Szuhai K, Bromme D: Cathepsin K is the principal proteas e in giant cell tumor of bone. Am J Pathol. 2004, 165: 593-600.PubMedCentralCrossRefPubMed

Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I: Interleukin-6 and soluble interleukin-6 receptors in the synovialfluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res. 1996, 11: 88-95.CrossRefPubMed

Collier FM, Huang WH, Holloway WR, Hodge JM, Gillespie MT, Daniels LL: Osteoclasts from human giant cell tumors of bone lack estrogen receptors. Endocrinology. 1998, 139: 1258-1267.PubMed

Atkins GJ, Kostakis P, Vincent C, Farrugia AN, Houchins JP, Findlay DM, Evdokiou A, Zannettino AC: RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J Bone Miner Res. 2006, 21: 1339-1349.CrossRefPubMed

Balke M, Campanacci L, Gebert C, Picci P, Gibbons M, Taylor R, Hogendoorn P, Kroep J, Wass J, Athanasou N: Bisphosphonate treatment of aggressive primary, recurrent and metastatic giant cell tumour of bone. BMC Cancer. 2010, 10: 462-PubMedCentralCrossRefPubMed

10.

Lackman RD, Hosalkar HS, Ogilvie CM, Torbert JT, Fox EJ: Intralesional curettage for grades II and III giant cell tumors of bone. Clin Orthop Relat Res. 2005, 438: 123e7-

11.

Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P, Follerås G: Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop. 2008, 79: 86-93.CrossRefPubMed

12.

Harness NG, Mankin HJ: Giant-cell tumor of the distal forearm. J Hand Surg. 2003, 29A: 188 e93-

13.

Jin CM, So RK, Myung JC, Yong CL: Multiple pulmonary metastases from giant cell tumor of a hand. Am J Med Sci. 2012, 343: 171-173.CrossRef

14.

Huvos AG: Tumors of histiocytic or fibrohistiocytic origin: giant cell tumor of bone. Bone Tumors, Diagnosis, Treatment, and Prognosis. Edited by: Huvos AG. 1991, Philadelphia: WB Saunders, 429-467. 2

15.

Kim TS, Park JS: Metastasising recurrent giant cell tumor: a case report. J Korean Bone Joint Tumor Soc. 2001, 7: 73-79.

16.

Mirra JM: Giant cell tumors. Bone Tumors; Clinical, Radiological, and Pathologic Correlations. Edited by: Mirra JM. 1989, Philadelphia: Lea and Febiger, 941-1020.

17.

Osaka S, Sugita H, Osaka E, Yoshida Y, Ryu J, Hemmi A, Suzuki K: Clinical and immunohistochemical characteristics of benign giant cell tumour of bone with pulmonary metastases: case series. Orthop Surg (Hong Kong). 2004, 12: 55-62.

18.

Siebenrock KA, Unni KK, Rock MG: Giant-cell tumor of bone metastasising to the lungs: a long-term follow-up. J Bone Joint Surg (Br). 1998, 80: 43-47.CrossRef

19.

Averill RM, Smith RJ, Campbell CJ: Giant cell tumors of the bones of the hand. J Hand Surg Am. 1980, 5: 39-50.CrossRefPubMed

20.

Ropars M, Kaila R, Cannon SR, Briggs TW: Primary giant cell tumours of the digital bones of the hand. J Hand Surg. 2007, 32B: 160 e4-

21.

Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S: Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol. 2010, 11: 275-280.CrossRefPubMed

22.

Werner M: Giant cell tumour of bone: morphological, biological and histogenetical aspects. Int Orthop. 2006, 30: 484-489.PubMedCentralCrossRefPubMed

23.

Tian R, Su M, Tian Y, Li F, Li L, Kuang A: Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions. Skeletal Radiol. 2009, 38: 451-458.CrossRefPubMed

24.

Cowan RW, Singh G: Giant cell tumor of bone: a basic science perspective. Bone. 2013, 52: 238-246.CrossRefPubMed

25.

Vincenzo G, Vincenzo DL: Role of p63 in cancer development. Biochim Biophys Acta. 1816, 2011: 57-66.

26.

Babeto E, Luis A, Curado V, Peitl P, Zuccari D: Differentially expressed genes in giant cell tumor of bone. Virchows Archiv. 2011, 458: 467-476.CrossRefPubMed

27.

Lawson L, VanLerberg N, Tawfik O: Pulmonary metastasis from a benign giant-cell tumor of the hand: report of a case diagnosed by fine-needle aspiration cytology. Diagn Cytopathol. 1996, 15: 157-160.CrossRefPubMed

28.

Goldenberg RR, Campbell CJ, Bonfiglio M: Giant-cell tumor of bone: an analysis of 218 cases. J Bone Joint Surg Am. 1970, 52: 619-664.PubMed

29.

Joly MA, Vazquez JJ, Martinez A, Guillen FJ: Blood-borne spread of a benign giant cell tumor from the radius to the soft tissue of the hand. Cancer. 1984, 54: 2564-2567.CrossRefPubMed

30.

Dominkus M, Ruggieri P, Bertoni F, Briccoli A, Picci P, Rocca M, Mercuri M: Histologically verified lung metastases in benign giant cell tumours-1 cases from a single institution. Int Orthop. 2006, 30: 499-504.PubMedCentralCrossRefPubMed

31.

Jacopin S, Viehweger E, Glard Y, Launay F, Jouve JL, Bouvier C, Bollini G: Fatal lung metastasis secondary to index finger giant cell tumor in an 8-year-old child. Orthop Traumatol Surg Res. 2010, 96: 310-313.CrossRefPubMed

32.

Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, Rossi G, Longhi A, Mercuri M: Giant cell tumor of the extremity: a review of 349 cases from a single institution. Cancer Treat Rev. 2010, 36: 1-7.CrossRefPubMed

33.

Kremen TJ, Bernthal NM, Eckardt MA, Eckardt JJ: Giant cell tumor of bone: are we stratifying results appropriately?. Clin Orthop Relat Res. 2012, 470: 677-683.PubMedCentralCrossRefPubMed

34.

Takeuchi A, Tsuchiya H, Niu X, Ueda T, Jeon D-G: The prognostic factors of recurrent GCT: a cooperative study by the Eastern Asian Musculoskeletal Oncology Group. J Orthop Sci. 2011, 16: 196-202.CrossRefPubMed

35.

Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH: Recurrent giant cell tumor of long bones analysis of surgical management. Clin Orthop Relat Res. 2011, 469: 1181-1187.PubMedCentralCrossRefPubMed

36.

Viswanathan S, Jambhekar NA: Metastatic giant cell tumor of bone: are there associated factors and best treatment modalities?. Clin Orthop Relat Res. 2010, 468: 827-833.CrossRefPubMed

37.

Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G: Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol. 2008, 134: 969-978.CrossRefPubMed

38.

Donthineni R, Boriani L, Ofluoglu O, Bandiera S: Metastatic behaviour of giant cell tumour of the spine. Int Orthop (SICOT). 2009, 33: 497-501.CrossRef

39.

Faisham WI, Zulmi W, Halim AS, Biswal BM, Mutum SS, Ezane AM: Aggressive giant cell tumour of bone. Singapore Med J. 2006, 47: 679-683.PubMed

40.

Prosser GH, Baloch KG, Tillman RM, Carter SR, Grimer RJ: Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone?. Clin Orthop Relat Res. 2005, 435: 211-218.CrossRefPubMed

41.

Su YP, Chen WM, Chen TH: Giant-cell tumors of bone: an analysis of 87 cases. Int Orthop. 2004, 28: 239-243.PubMedCentralCrossRefPubMed

42.

Trieb K, Bitzan P, Lang S, Dominkus M, Kotz R: Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy. Eur J Surg Oncol. 2001, 27: 200-202.CrossRefPubMed

43.

Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS: Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am. 1999, 81: 811-820.CrossRefPubMed

44.

O’Donnell RJ, Springfield DS, Motwani HK, Ready JE, Gebhardt MC, Mankin HJ: Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am. 1994, 76: 1827-1833.PubMed

45.

Kay RM, Eckardt JJ, Seeger LL, Mirra JM, Hak DJ: Pulmonary metastasis of benign giant cell tumor of bone: six histologically confirmed cases, including one of spontaneous regression. Clin Orthop. 1994, 302: 219-230.PubMed

46.

McDonald DJ, Sim FH, McLeod RA, Dahlin DC: Giant-cell tumor of bone. J Bone Joint Surg Am. 1986, 68: 235-242.PubMed

47.

Rock MG: Curettage of giant-cell tumor of bone: factor influencing local recurrences and metastasis. Chir Organi Mov. 1990, 75 (Suppl. 1): 204-205.PubMed

48.

Tubbs WS, Brown LR, Beabout JW, Rock MG, Unni KK: Benign giant-cell tumor of bone with pulmonary metastases: clinical findings and radiologic appearance of metastases in 13 cases. AJR Am J Roentgenol. 1992, 158: 331-334.CrossRefPubMed

49.

Kim Y, Nizami S, Goto H, Lee FY: Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor. Clin Orthop Surg. 2012, 4: 107-116.PubMedCentralCrossRefPubMed

50.

Eckardt JJ, Grogan TJ: Giant cell tumor of bone. Clin Orthop Relat Res. 1986, 204: 45-58.PubMed

51.

Faisham WI, Zulmi W, Mutum SS, Shuaib IL: Natural history of giant cell tumour of the bone. Singapore Med J. 2003, 44: 362-365.PubMed

52.

Knochentumoren A: Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am. 2008, 90: 1060-1067.CrossRef

53.

Mendenhall WM, Zlotecki RA, Scarborough MT, Gibbs CP, Mendenhall NP: Giant cell tumor of bone. Am J Clin Oncol. 2006, 29: 96-99.CrossRefPubMed

54.

Wang HC, Chien SH, Lin GT: Management of grade III giant cell tumors of bones. J Surg Oncol. 2005, 92: 46-51.CrossRefPubMed

55.

Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, Moreau G, Davis AM: Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res. 2002, 397: 248-258.CrossRefPubMed

56.

Malek F, Krueger P, Hatmi ZN, Malayeri AA, Faezipour H, O’Donnell RJ: Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy. Int Orthop. 2006, 30: 495-498.PubMedCentralCrossRefPubMed

57.

McGough RL, Rutledge J, Lewis VO, Lin PP, Yasko AW: Impact severity of local recurrence in giant cell tumor of bone. Clin Orthop Relat Res. 2005, 438: 116-122.CrossRefPubMed

58.

Campanacci M:Bone and Soft Tissue Tumors. 1999, New York, NY: Springer, 2,CrossRef

59.

Tse LF, Wong KC, Kumta SM, Huang L, Chow TC, Griffith JF: Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone. 2008, 42: 68-73.CrossRefPubMed

60.

Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, Jun S, Jacobs I: Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res. 2012, 18: 4415-4424.CrossRefPubMed

61.

Hamann C, Lützner J, Wieczorek K, Hofbauer LC: Pulmonary metastases due to a giant-cell tumor of bone. J Clin Endocrinol Metab. 2012, 97: 3408-3409.CrossRefPubMed

62.

Gupta R, Seethalakshmi V, Jambhekar NA, Prabhudesai S, Merchant N, Puri A, Agarwal M: Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western India. Ann Diagn Pathol. 2008, 12: 239-248.CrossRefPubMed

Title: Pulmonary metastasis of giant cell tumor of bones
Authors: Aikeremujiang Muheremu
Xiaohui Niu
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2014
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/1477-7819-12-261

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Pulmonary metastasis of giant cell tumor of bones

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Spontaneous rupture of a giant gastrointestinal stromal tumor of the jejunum: a case report and literature review

Synchronous ipsilateral carcinoma of the accessory mammary gland and primary lymphoma of the breast with subsequent rectal carcinoma: report of a case

En bloc resection and bone graft: does it alter the natural history of monostotic expansile fibrous dysplasia in children?

Trends in clinical features, postoperative outcomes, and long-term survival for gastric cancer: a Western experience with 1,278 patients over 30 years

Renal metastasis after esophagectomy of esophageal squamous cell carcinoma: a case report and literature review

High expression of periostin is dramatically associated with metastatic potential and poor prognosis of patients with osteosarcoma